Your AI-Trained Oncology Knowledge Connection!

CAR-T Referral Process: Insights from UCSF : Episode 1

Introduction and CAR-T Therapy in Earlier Lines of Treatment for R/R Multiple Myeloma

December 23, 2024

Opinion

Video

A panel of experts discuss CAR T therapy in earlier lines of treatment within the R/R multiple myeloma treatment paradigm.

EP: 1.Introduction and CAR-T Therapy in Earlier Lines of Treatment for R/R Multiple Myeloma

EP: 2.Decision Points for Using CAR T-Cell Therapy in Early Lines of Treatment

EP: 3.Second-Line Treatment for R/R Multiple Myeloma: Who Is the “Right Patient”?

EP: 4.Referral Process for CAR T-Cell Therapy: Initial Contact Through Patient Evaluation and Selection

EP: 5.CAR T-Cell Therapy: CAR T-Cell therapy Process and Bridging Therapy

EP: 6.Co-Management and Co-Monitoring of Patients Receiving CAR T-Cell Treatment: Transitions Between the Academic and Community Centers

EP: 7.Management of Adverse Events of Special Interest in Patients Receiving CAR -T-Cell Therapy for R/R Multiple Myeloma: Diarrhea, Guillain-Barrée Syndrome, Parkinson’s Disease, and Secondary Malignancies

EP: 8.Example of Successful Collaboration with a Referring Community Practice

EP: 9.CAR T-Cell Therapy in Multiple Myeloma: Lessons Learned and Key Takeaways

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos

1 expert is featured in this series.

2 experts are featured in this series.

2 experts are featured in this series.

OncNursingNews.com

TargetedOnc.com

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.